«RGBP is working on getting regulatory approval and executing clinical trials in cell therapy. The company produces medicines for diabetes, heart-related illness, circulatory issues, and Chronic Obstructive Pulmonary Disease.»
Don't you think if this would be a shady company or CEO, this big company ONPH would bother to do deals after deals with RGBP? I got your half way cooked points but something is off on what you are saying...